Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)
NCT00162929
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Breast Cancer
Interventions
BIOLOGICAL:
AdHer-2/neu transduced dendritic cells
Sponsor
Ontario Clinical Oncology Group (OCOG)
Collaborators
[object Object]
[object Object]